E-LIB Suche - Ergebnisse für: Chen, L-T

1

279MO Three-year survival, safety and extended long-term su..:

Oh, D-Y. ; He, A.R. ; Qin, S....
Annals of Oncology. 35 (2024) - p. S117 , 2024

Link: https://doi.org/10.1016/..

2

KLF10 loss in the pancreas provokes activation of SDF-1 and..:

Weng, C-C ; Hawse, J R ; Subramaniam, M...
Oncogene. 36 (2017) 39 - p. 5532-5543 , 2017

Link: https://doi.org/10.1038/..

3

Erratum: miR-520h is crucial for DAPK2 regulation and breas..:

Su, C-M ; Wang, M-Y ; Hong, C-C...
Oncogene. 36 (2017) 41 - p. 5770-5770 , 2017

Link: https://doi.org/10.1038/..

4

Helicobacter pylori-related diffuse large B-cell lymphoma o..:

Kuo, S-H ; Yeh, K-H ; Chen, L-T...
Blood Cancer Journal. 4 (2014) 6 - p. e220-e220 , 2014

Link: https://doi.org/10.1038/..

5

Genetic polymorphisms and tissue expression of interleukin-..:

Liao, F ; Hsu, Y-C ; Kuo, S-H...
Blood Cancer Journal. 4 (2014) 10 - p. XX-XX , 2014

Link: https://doi.org/10.1038/..

6

PCN147 MEDICAL RESOURCES UTILIZATION OF FIVE MOST PREVALENT..:

Liu, JS ; Chen, LT ; Hsiao, CF
Value in Health. 13 (2010) 7 - p. A279 , 2010

Link: https://doi.org/10.1016/..

7

PCN113 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALI..:

Chen, HH ; Chang, CS ; Chen, LT...
Value in Health. 12 (2009) 7 - p. A278 , 2009

Link: https://doi.org/10.1016/..

8

PCN36 COST-MINIMIZATION ANALYSIS OF CAPECITABINE FOR ADVANC..:

Chang, CS ; Chao, Y ; Chen, JS...
Value in Health. 11 (2008) 3 - p. A64-A65 , 2008

Link: https://doi.org/10.1016/..

9

CN2 PHARMACOECONOMIC ANALYSIS OF CAPECITABINE IN ADJUVANT T..:

Hsu, TC ; Chen, HH ; Chen, LT...
Value in Health. 10 (2007) 3 - p. A11-A12 , 2007

Link: https://doi.org/10.1016/..

10

Differential response to H. pylori eradication therapy of c..:

Kuo, S‐H ; Chen, L‐T ; Wu, M‐S...
The Journal of Pathology. 211 (2006) 3 - p. 296-304 , 2006

Link: https://doi.org/10.1002/..

11

Pricing and lot-sizing for a deteriorating item in a period..:

Chen, J-M ; Chen, L-T
Journal of the Operational Research Society. 55 (2004) 8 - p. 892-901 , 2004

Link: https://doi.org/10.1057/..

12

Trial Designs for Integrating Novel Therapeutics into the M..:

Su YY ; Liu YS ; Hsiao CF..
https://www.dovepress.com/trial-designs-for-integrating-novel-therapeutics-into-the-management-o-peer-reviewed-fulltext-article-JHC. , 2022

Link: https://doaj.org/article..

13

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20)..:

Chang, K-Y ; Chiang, N-J ; Wu, S-Y...
OncoImmunology. , 2021

Link: https://qmro.qmul.ac.uk/..

14

Two first-in-human studies of xentuzumab, a humanised insul..:

de Bono, J ; Lin, C-C ; Chen, L-T...
British journal of cancer, 2020, 122 (9), pp. 1324 - 1332. , 2020

Link: https://repository.icr.a..

15

Two first-in-human studies of xentuzumab, a humanised insul..:

de Bono, J ; Lin, C-C ; Chen, L-T...
https://eprints.whiterose.ac.uk/179681/1/Two%20first-in-human%20studies%20of%20xentuzumab,%20a%20humanised%20insulin-like%20growth%20factor%20%28IGF%29-neutralising%20antibody,%20in%20patients%20wi.pdf. , 2020

Link: https://eprints.whiteros..